Showing 3,181 - 3,200 results of 21,342 for search '(( significant decrease decrease ) OR ( significant ((gap decrease) OR (a decrease)) ))*', query time: 0.73s Refine Results
  1. 3181
  2. 3182

    UTI diagnoses by sex and physician specialty (2013–2019). by Thomas Hanslmeier (19949694)

    Published 2024
    Subjects: “…fluoroquinolone shares decreased…”
  3. 3183

    Arrangement of PHC facilities in a woreda NoCs. by Gizachew Tadele Tiruneh (8407686)

    Published 2025
    “…The <i>"Improve Primary Health Care Service Delivery (IPHCSD)"</i> project, implemented by JSI and Amref Health Africa since April 2022, seeks to address these gaps through a Networks of Care (NoCs) approach. …”
  4. 3184
  5. 3185
  6. 3186

    Table2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  7. 3187

    Table1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.DOCX by Sofia Schaeffer (20379954)

    Published 2024
    “…<p>Metabolic dysfunction–associated steatotic liver disease (MASLD) is a multisystemic disease with a multifactorial pathogenesis involving dietary, environmental, and genetic factors. …”
  8. 3188
  9. 3189
  10. 3190
  11. 3191
  12. 3192
  13. 3193
  14. 3194
  15. 3195
  16. 3196
  17. 3197
  18. 3198
  19. 3199

    PP1/PP2A does not dephosphorylate pS295 <i>in vitro</i>. by Takahiko Chimura (729098)

    Published 2024
    “…The decrease of phosphorylated GSK3β (pGSK3β(S9)) was completely suppressed by the PP1/PP2A inhibitor calyculin A. …”
  20. 3200